Clinical Trial Update: Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Fudan University is evaluating adebrelimab in combination with NALIRIFOX for locally advanced pancreatic cancer and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Liposomal irinotecan (liposomal irinotecan)

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING